TY  - JOUR
AU  - Mishra, Vikash Chandra
AU  - Chandra, Dinesh
AU  - Raina, Vimarsh
PY  - 2025
DA  - 2025/11/25
TI  - Risk Assessment in Clinical Histocompatibility Testing: Challenges, Strategies, and Future Directions
JO  - OBM Transplantation
SP  - 260
VL  - 09
IS  - 04
AB  - Though the role of clinical histocompatibility testing is fundamental to successful transplant, systematic risk assessment and mitigation strategies remain underutilised in this domain. This review addresses risk identification, analysis, and control measures across the pre-analytical, analytical, and post-analytical phases of clinical histocompatibility testing, in line with international standards such as ISO 15189:2022. A structured, risk-based quality management system (QMS) is imperative for ensuring accurate testing, timely reporting, and subsequently optimal transplant outcomes. Future directions include leveraging digital tools and fostering a culture of continuous improvement in histocompatibility laboratories.
SN  - 2577-5820
UR  - https://doi.org/10.21926/obm.transplant.2504260
DO  - 10.21926/obm.transplant.2504260
ID  - Mishra2025
ER  -